Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
4.050
-0.200 (-4.71%)
At close: Dec 5, 2025, 4:00 PM EST
4.000
-0.050 (-1.23%)
After-hours: Dec 5, 2025, 5:11 PM EST
LIXT Employees
Lixte Biotechnology Holdings had 2 employees as of December 31, 2024. The number of employees decreased by 2 or -50.00% compared to the previous year.
Employees
2
Change (1Y)
-2
Growth (1Y)
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$2,066,844
Market Cap
23.10M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
LIXT News
- 3 days ago - LIXTE Levels Up From PP2A Innovation to Multi-Modal Oncology - Accesswire
- 3 days ago - LIXTE Steps Into a Key Role in the Rise of Treatment Amplifiers - Accesswire
- 11 days ago - LIXTE Biotechnology Acquires Liora Technologies' Proprietary Proton Therapy Platform for Cancer Treatment - GlobeNewsWire
- 5 weeks ago - LIXTE Biotechnology Holdings to Present at the Spartan Capital Investor Conference 2025, November 3 - GlobeNewsWire
- 7 weeks ago - LIXTE Biotechnology Holdings Highlights Q4 2025 Priorities, Including Ongoing Advancement of Lead Candidate LB-100, Strategic Oncology Business Development and Acquisition Plans - GlobeNewsWire
- 2 months ago - LIXTE's Bold Blueprint to Rewire Cancer's Master Switch and Redefine Its Own Future (NASDAQ: LIXT) - Accesswire
- 2 months ago - LIXTE Bio's Transformational Summer Marked by Leadership Updates, Scientific Progress, and Digital Treasury Strategy (NASDAQ:LIXT) - Accesswire
- 3 months ago - LIXTE Biotechnology Holdings Makes $2.6 Million Initial Purchase of Digital Currency to Diversify Treasury and for Potential Acquisitions - GlobeNewsWire